SEC Form 4 · accession 0001144204-16-094893
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President and CEO · Director
Period of report
Apr 16, 2016
Accepted (ET)
Apr 18, 2016 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 16, 2016 | F | 1,161 | $43.25 | D | 177,910 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy tax withholding obligation upon the vesting of 3,750 shares of restricted stock.